Nimbus Healthcare

What Nimbus Healthcare does

Nimbus Healthcare Corporation is a vertically integrated, telehealth-enabled precision medicine company founded in 2021 in Austin, Texas, by pharmacist Dr. Jobby John. The company delivers data-driven programs for medical weight loss (WeightWise RX, featuring proprietary compounded GLP-1 formulations CarniSema® and CarniTide®), hormone optimization (NimCore® Men and forthcoming Women), and DNA-guided hair restoration (HairWise GX), with a newly launched nutrition program (Nimbus Meals) co-developed with Snap Kitchen. Its core technological and operational differentiator is full-stack vertical integration: Nimbus owns and operates Lake Hills Pharmacy, a NABP-accredited 503A compounding facility licensed in 37 states, where every medication is formulated, sterility-tested, endotoxin-tested, and shipped directly to patients or provider partners. The platform layers IntelliHealth™ — an in-house AI clinical decision support system — and the Nimy personal AI health guide on top of prescribing, lab ordering (via Quest Diagnostics), and pharmacy fulfillment, creating a single continuous care loop from intake through ongoing titration.

The company serves three primary customer segments: (1) individual consumers seeking medical weight loss, hormone optimization, or hair restoration through a self-serve digital intake quiz followed by clinician-led telemedicine; (2) healthcare providers and clinics (including med spas, wellness centers, and chiropractors) who prescribe from a 160+ compound catalog via a white-label platform with enterprise dashboard and same-day launch; and (3) employers offering GLP-1 therapy paired with medically tailored meals as a corporate wellness benefit. Revenue is generated through recurring subscription plans (priced from $125/month for hormone programs to $129-$299/month for GLP-1 therapy, with multi-month plans offering up to 28% discounts), per-patient B2B2C economics of $1,923+ per patient per year for clinic partners, and employer benefit deployments processed with HSA/FSA compatibility via Prado. Flat-rate pricing across all doses, NABP-accredited compounding, AI-augmented clinical decision support, and direct-to-patient fulfillment underpin the company's positioning against fragmented telehealth and pharmacy competitors.

Name

Nimbus Healthcare

Legal name

Nimbus Healthcare Corporation

Website

https://nimbushealthcare.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

51–100 employees

Short description

Nimbus Healthcare is a vertically integrated Austin-based telehealth and compounding pharmacy company that delivers physician-led GLP-1 weight loss, hormone optimization, and hair restoration programs directly to consumers, provider clinics, and employers across 35+ US states.

Ownership category

akta.pro rank

Product category

Telehealth and compounding pharmacy services

NAICS

Medical Equipment and Supplies Manufacturing (3391)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Provider/Health-System Telehealth + In-House/Owned Pharmacy Integration (HLALAIAB)

akta.pro secondary industries

Specialty Pharmacy–Integrated Telehealth (biologics, complex therapies, REMS) (HLALAIAF), Primary Care & General Medicine Virtual Care (HLALAAAA), Pharmacy-Integrated Virtual Care & ePrescribing (Employer Benefit) (HLALADAH)

Keywords

• GLP-1 weight loss therapy
• Compounding pharmacy services
• Hormone optimization programs
• Hair restoration treatments
• Telehealth precision medicine

Headquarters

HQ city

Austin

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Subscription Plans (WeightWise RX): Monthly subscription plans for GLP-1 weight loss therapy. Patients select 1-month, 3-month, or 6-month plans with locked-in pricing. Flat-rate pricing across any dose with no upcharges as dose increases. Revenue recognized over subscription term. 6-month plan offers highest savings (28% vs 1-month) and lowest monthly rate, creating land-and-expand dynamics.
2. Subscription Plans (NimCore Men): Monthly membership at $125/mo for hormone optimization including 3 comprehensive lab panels per year, clinician chat, video consultations, and dose adjustments. Medications (testosterone, HCG, anastrozole, etc.) billed separately at member-only pharmacy pricing.
3. One-Time Test Kits: Women's Hormone Test Kit sold as a one-time purchase ($249) including at-home sample collection, lab analysis of 6 biomarkers (estradiol, progesterone, cortisol, thyroid, testosterone, DHEA), and a free telemedicine consult to review results and map next steps.
4. B2B2C Provider / Clinic Subscriptions: Revenue per patient, per year model for clinic partners ($1,923+ per patient annually). No insurance billing; cash-pay model means revenue hits account at point of transaction. No platform fees for trial; providers prescribe from Nimbus's compound catalog and earn margins on pharmacy fulfillment. Scales with patient volume and number of programs offered.
5. Employer Benefit Deployment: Nimbus Meals program offered as an employer-deployed benefit, pairing GLP-1 therapy with medically tailored meals from Snap Kitchen. HSA/FSA checkout via Prado enables pre-tax benefit utilization.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels7 records

Core offering

Nimbus Healthcare is a vertically integrated telehealth and pharmacy platform that delivers physician-led GLP-1 weight loss therapy (WeightWise RX), hormone optimization (NimCore), and DNA-guided hair restoration (HairWiseGX). The company owns and operates Lake Hills Pharmacy, a NABP-accredited 503A compounding facility in Austin, TX, where proprietary formulations such as CarniSema® (Semaglutide + L-Carnitine) and CarniTide® (Tirzepatide + L-Carnitine) are compounded and shipped directly to patients.

Product overview

Nimbus Healthcare is a vertically integrated telehealth and pharmacy platform built around its owned NABP-accredited 503A compounding pharmacy (Lake Hills Pharmacy). The platform offers four core programs: WeightWise rx GLP-1 Plan (featuring proprietary compounded formulations CarniSema® and CarniTide®), NimCore® Hormone Optimization (with NimCore Men and NimCore Women programs), HairWiseGX hair restoration, and the Nimbus Meals nutrition program in partnership with Snap Kitchen. Supporting infrastructure includes the IntelliHealth™ clinical decision support system, Nimy AI health guide, Nimbus Member Portal, and a white-label provider platform for clinic partners. The platform connects intake, clinician oversight, precision compounding, and ongoing patient support into one continuous care loop.

Differentiator

Problem solved

Functional benefit

Brands

• WeightWise: GLP-1 weight loss program featuring compounded semaglutide (CarniSema®) and tirzepatide (CarniTide®) with ongoing clinical support.
• NimCore®
• HairWise / Hair Restoration
• Nimbus Meals
• CarniSema®
• CarniTide®
• The Honest Dose
• IntelliHealth™

Products and services

• WeightWise RX GLP-1 Plan Medical weight loss program offering physician-prescribed GLP-1 medications with ongoing clinical support, dose adjustments, and medications compounded at the company's NABP-accredited pharmacy. Targets adults with overweight or obesity seeking sustainable, clinically managed weight loss.
• NimCore® Men Hormone Optimization Physician-led hormone optimization subscription for men at $125/month including three annual comprehensive lab panels (70+ biomarkers), video consultations, continuous clinician chat, and member-only pricing on compounded therapies (testosterone, HCG, anastrozole). Targets men experiencing age-related hormone decline.
• NimCore® Women Hormone Optimization Physician-led hormone optimization program for women designed to analyze unique biology and optimize energy, performance, and focus through personalized hormone testing and treatment protocols. Targets women experiencing symptoms of hormone imbalance.
• Nimbus Women's Hormone Test Kit One-time at-home hormone panel evaluating six biomarkers (estradiol, progesterone, cortisol, thyroid, total testosterone, DHEA) with a free telemedicine consult to review results and map next steps. Sold at $249 per kit.
• HairWiseGX DNA-Guided Hair Restoration Hair restoration program combining genetic testing, clinician guidance, and custom-compounded formulations (minoxidil, finasteride, and other compounds). Available in all 50 states and targets adults experiencing hair loss who want DNA-guided treatment.
• Nimbus Provider Platform B2B white-label platform for healthcare providers and clinics to prescribe GLP-1s, peptides, hormone optimization, and longevity protocols from Nimbus's 160+ compound catalog. Includes enterprise dashboard for multi-location visibility, HIPAA-compliant telemedicine, direct-to-patient pharmacy fulfillment, and same-day launch with under 2 hours of staff training. Generates $1,923+ revenue per patient per year for clinic partners.
• Nimbus Meals 12-week meal program pairing GLP-1 therapy with medically tailored, ready-to-heat meals designed to reduce side effects, support protein intake, and sustain weight loss results. Available via individual subscription and employer deployment, with HSA/FSA checkout powered by Prado.

Quantifiable outcome

• 87% of WeightWise members lost 20+ lbs in 3 months
• +3 more outcomes

Named customers1 record

Segments6 records

Ideal customer profiles6 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability4 records

Feature6 records

Partnerships

Three partnerships are on record, tiered core.

• Snap KitchencoreStrategic or Co-development Partner · 1 January 2026Nimbus Healthcare and Snap Kitchen co-launched 'Nimbus Meals,' a 12-week program combining GLP-1 medication management with physician-designed ready-to-heat meals. The program addresses patient adherence challenges during GLP-1 treatment by pairing clinical care with nutritionally optimized meals designed to reduce side effects, support protein intake, and sustain weight loss. Available via individual subscription and employer deployment, with HSA/FSA checkout powered by Prado. Launched January 2026 starting in Texas before expanding to additional cities and employer partners.
• Quest DiagnosticscoreTechnology or IntegrationQuest Diagnostics provides laboratory testing services for NimCore Men hormone optimization program. Three comprehensive lab panels per year (baseline, 90-day, annual) are included in the $125/month membership with no separate lab fee. At-home blood draw options also available as an alternative to in-person Quest visits.
• IntelliHealthcoreTechnology or IntegrationIntelliHealth (built by Nimbus's in-house clinical team of pharmacists and physicians) provides clinical decision support integrated into the Nimbus platform for all programs. Surfaces the signal from patient data; physician calls the shots. Powers protocol guidance, drug interaction checks, and lab range analysis for both patient-facing and provider-facing workflows.

Scale indicators8 records

Recent moves6 records

Expansion highlights7 records

Direct peers

• Hims & Hers Health: Hims & Hers is a publicly traded D2C telehealth platform offering weight-loss (including GLP-1s via partner pharmacy), hair restoration, and hormone treatments. Directly comparable to Nimbus on consumer telehealth positioning, subscription pricing, and cash-pay model, but at vastly larger scale and with broader brand reach.
• Ro: Ro operates a D2C telehealth platform with weight management (including compounded GLP-1s), hormone optimization, and men's health offerings. Comparable to Nimbus on multi-vertical cash-pay telehealth, vertically integrated pharmacy, and B2B2C provider partnerships.
• LifeMD: LifeMD runs a D2C telehealth business with significant weight-loss (GLP-1) and hormone therapy offerings through brands like Hers and Rex MD. Directly comparable to Nimbus on cash-pay subscription model, vertically integrated pharmacy fulfillment, and clinical decision support infrastructure.
• Henry Meds: Henry Meds is a telehealth platform specializing in compounded GLP-1 weight-loss therapy with subscription pricing. Directly comparable to Nimbus's WeightWise program on cash-pay model, compounded medication positioning, and D2C online intake flow.
• Mochi Health: Mochi Health is a D2C telehealth provider focused on medical weight loss using compounded GLP-1s, with clinician oversight and ongoing care. Closely comparable to Nimbus's WeightWise program on cash-pay subscription, California-style pricing structure, and online intake funnel.
• Remedy Meds: Remedy Meds is a telehealth platform offering compounded GLP-1 weight-loss therapy with subscription plans. Comparable to Nimbus's WeightWise on flat-rate cash-pay subscription model, online intake, and direct-to-patient pharmacy fulfillment.

Emerging players

• Evexias Health Solutions: Evexias Health Solutions provides hormone optimization, peptide therapy, and weight management through a network of providers. Comparable to Nimbus's NimCore and WeightWise programs from a hormone and longevity focus, with overlap on provider/B2B2C channel.
• Defy Medical: Defy Medical is a telehealth provider specializing in hormone replacement therapy, peptides, and wellness treatments for both men and women. Comparable to Nimbus's NimCore hormone optimization offering with overlap on cash-pay model and personalized protocols.

Broad incumbents

• Teladoc Health: Teladoc is a large publicly traded telehealth platform serving employers, health plans, and providers across a wide range of conditions. Comparable to Nimbus's telehealth infrastructure but as a broad incumbent offering virtual care as part of a much larger portfolio rather than specializing in weight loss or hormone optimization.
• Eli Lilly (Zepbound / LillyDirect): Eli Lilly is the manufacturer of branded tirzepatide (Zepbound) and operates LillyDirect, a direct-to-patient channel for its branded GLP-1s. Comparable to Nimbus's WeightWise program from a competitive standpoint, as the branded drug manufacturer and operator of a competing cash-pay online channel.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@NimbusHealthcare

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Subsidiaries1 record

Funding overview

Funding rounds3 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nimbus Healthcare